Young Jun Park

Young Jun Park

Auto-generated profile, based on publicly available information

Young Jun Park

Division of Vascular and Transplant Surgery, Department of Surgery, Yeouido ST. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2018 in Energy and Buildings
Verified
Journal Article
Closed access
JKJi-Myong Kim
Ji-Myong Kim
YPYoung Jun Park
Young Jun Park
Kiyoung SonKiyoung Son
Kiyoung Son
YKYoung-Jae Kim
Young-Jae Kim

27 April 2022 in Therapeutic Apheresis and Dialysis
Verified
Journal Article
Closed access
SYSang Seob Yun
Sang Seob Yun
SMSangkyun Mok
Sangkyun Mok
SPSun Cheol Park
Sun Cheol Park
YPYoung Jun Park
Young Jun Park
JKJang Yong Kim
Jang Yong Kim

1 March 2022 in Annals of Vascular Surgery
Verified
Journal Article
Closed access
YPYoung Jun Park
Young Jun Park
SMSangkyun Mok
Sangkyun Mok
SPSun Cheol Park
Sun Cheol Park
SYSang Seob Yun
Sang Seob Yun
JKJang Yong Kim
Jang Yong Kim

1 January 2021 in Annals of Surgical Treatment and Research
Verified
Journal Article
Open access
PDF file
YPYoung Jun Park
Young Jun Park
SMSangkyun Mok
Sangkyun Mok
JKJang Yong Kim
Jang Yong Kim
SYSang Seob Yun
Sang Seob Yun
SPSun Cheol Park
Sun Cheol Park
Park YJ, et al. Ann Surg Treat Res. 2021 Dec;101(6):368-373. https://doi.org/10.4174/astr.2021.101.6.368

25 March 2025 in Annals of Transplantation
Verified
Journal Article
Open access
SMSangkyun Mok
Sangkyun Mok
SPSun Cheol Park
Sun Cheol Park
SYSang Seob Yun
Sang Seob Yun
YPYoung Jun Park
Young Jun Park
DSDongin Sin
Dongin Sin
JHJung K. Hyun
Jung K. Hyun
The optimization of tacrolimus dosing during the early postoperative hospitalization period is essential to prevent rejection, minimize nephrotoxicity, and minimize the risk of opportunistic infections. Patient pharmacokinetic variability poses challenges in dose adjustment. This study aimed to evaluate tacrolimus dosing optimization using machine learning and statistical methods. We conducted a retrospective study of 749 kidney transplant recipients at Seoul St. Mary’s Hospital between January 2015 and December 2019. Data on tacrolimus doses, trough levels, and other clinical variables were collected and analyzed during the first 12 postoperative days of hospitalization. Three approaches were evaluated: Extreme Gradient Boosting (XGBoost), Elastic Net regression (EN), and Linear regression (LR). The models were trained and validated using 5-fold cross-validation, with performance assessed using R2 errors and alignment with clinically acceptable error margins. Elastic Net showed the best performance with R2 (Coefficient of Determination) of 0.861±0.044 and RMSE (Root Mean Square Error) of 0.930±0.220. Linear Regression and XGBoost provided clinically relevant predictions but with slightly lower accuracy. External validation was not performed, limiting the generalizability of the results. The Elastic Net is a practical and reliable model for predicting the optimal tacrolimus dose. Machine learning and statistical methods are useful tools for optimizing tacrolimus dosing during hospitalization after kidney transplantation. Future studies should incorporate multi-center validation to improve clinical applicability.

23 March 2022 in Vascular
Verified
Journal Article
Closed access
YPYoung Jun Park
Young Jun Park
SMSangkyun Mok
Sangkyun Mok
JKJang Yong Kim
Jang Yong Kim
SPSun Cheol Park
Sun Cheol Park
SYSang Seob Yun
Sang Seob Yun
Objectives: Current guidelines recommend initial postoperative follow-up with computed tomography angiography (CTA) after endovascular aneurysm repair (EVAR). However, CTA has risks associated with ionizing radiations and nephrotoxic contrast agents. We investigated possibilities to replace the initial postoperative CTA with contrast enhanced duplex ultrasound (CE-DUS) in selected patients. Methods: Out of the 273 consecutive patients who underwent EVAR, 173 were excluded and the 100 patients who underwent CTA and CE-DUS imaging concurrently (≤1 month interval between CTA and CE-DUS imaging) within 60 days after EVAR were analyzed. Patients who underwent EVAR outside the manufacturer’s instructions for use or who had endoleaks discovered on intraoperative angiography were classified as the high-risk group, otherwise, they were classified as the low-risk group. Measurements of diagnostic values of CE-DUS ​​related to the detection of complications were calculated using CTA as the gold standard. McNemar’s test was performed to compare these values and Pearson correlation coefficient was derived to compare CE-DUS measurements of sac diameters with CTA. Results: In the low-risk group, no difference was observed between CE-DUS and CTA in the detection of EVAR-related complications (sensitivity = 0.95, specificity = 0.93). In the high-risk group, CE-DUS was not as accurate as CTA for the detection of overall EVAR-related complications (sensitivity = 0.57, specificity = 0.86, p = 0.04) and for the detection of complications other than endoleaks ( p = 0.02). Regarding sac diameter measurement, there was good agreement between CE-DUS and CTA ( r = 0.92, p < 0.001). Conclusions: First postoperative CE-DUS was reliable for the evaluation of EVAR-related complications compared to CTA in selected patients. Individualized EVAR follow-up strategy using CE-DUS based on the initial risk of EVAR-related complications should be considered.